PQA is celebrating its 20th year in 2026. In addition to special events at the 2026 PQA Annual Meeting in Baltimore, Md., May 12-14, PQA will recognize across the year the people, milestones and achievements that have defined the organization’s success. We also will look to the future and PQA’s continuing work to improve the quality of medication use.
Artificial intelligence (AI) is reshaping health care, including how medications are used. On November 13, 2025, PQA hosted PQA Convenes: Artificial Intelligence in Medication Use Quality to bring together PQA members, health technology leaders, and other stakeholders for a discussion on how AI and machine learning are being used to identify, understand, and engage patients in their medication use.
PQA Is Launching a Heart Failure Technical Expert Panel
In 2026, the Pharmacy Quality Alliance (PQA) marks an extraordinary milestone: 20 years of advancing medication use quality and improving patient outcomes across the United States.
The PQA Kelman Quality Leadership Program helps individuals at various career stages become leaders in health care quality that is focused on safe, effective and appropriate medication use. Through education, training and mentorship, the program has components for students, early career professionals and emerging leaders that support long-term professional development and advancement towards leadership positions.
Welcome to Five For Friday!
PQA convenes two standing technical expert panels – the Quality Metrics Expert Panel (QMEP) and Measure Update Panel (MUP) – to support PQA’s systematic, transparent, and consensus-based process for measure development and maintenance.
The Centers for Medicare & Medicaid Services strengthened its commitment to monitoring patient safety with the addition of several PQA safety measures to the 2027 Part D Star Ratings (Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults [POLY-ACH], and Concurrent Use of Opioids and Benzodiazepines [COB]) and Display Page (Polypharmacy: Use of Multiple CNS-Active Medications in Older Adults [POLY-CNS]). A new publication in the Journal of Managed Care and Specialty Pharmacy provides insights into the quality issues associated with CNS-active medication polypharmacy suggesting that the rate of CNS-active polypharmacy is higher among enrollees of the Medicare Part D Medication Therapy Management (MTM) program compared to the general Medicare Fee-For-Service population. This finding isn’t surprising given the eligibility and targeting criteria for the Part D MTM program.
Welcome to Five For Friday!
Welcome to Five For Friday!
PQA has appointed individuals from member organizations to serve on the 2026 PQA Measure Update Panel (MUP) and Quality Metrics Expert Panel (QMEP).
Early in the measure life cycle, PQA solicits multi-stakeholder input to evaluate and prioritize health plan measure concepts for future development. To support measure conceptualization in 2025, PQA convened a Measure Concept Advisory Group (MCAG) and conducted a public comment period to inform future measure development, with a particular focus on addressing meaningful gaps in medication use quality while ensuring measure concepts are evidence-based and usable in real-world settings.
The PQA Quality Leadership Program expanded in 2025 to increase opportunities for all professionals at PQA member organizations and students to hone their skills in medication use quality and gain valuable knowledge about PQA’s measure development process and the measure life cycle.
Welcome to Five For Friday!
A research partnership between PQA, Merck, and the University of Mississippi focused on three PQA adherence measures to continue to monitor their impact.
Welcome to Five For Friday!
Welcome to Five For Friday!
Welcome to Five For Friday!
PQA, the Pharmacy Quality Alliance, will launch a new Patient Advisory Council in 2026. This council will advise PQA on what matters most to patients, their families and caregivers as it relates to safe, effective and appropriate medication use.
This guest blog is one in a series by sponsors of the 2025 PQA Leadership Summit on how health plans are rebuilding trust and driving change locally. PQA does not endorse, recommend or favor any product, service or organization that is a sponsor.
